Good outcomes in revascularizing high-risk, complex PCI patients start with careful patient selection. The heart team at VA North Texas Healthcare System in Dallas shares their decision-making process for patient selection for Protected PCI.

A meta-analysis of randomized trials found that treating infrapopliteal arteries with drug-coated balloons was associated with similar clinical outcomes and favorable angiographic efficacy compared with using uncoated balloons or drug-eluting stents.

Researchers found the clinical success rates were above 99 percent and similar in patients undergoing robotically assisted PCI or manual PCI.

Patients with atrial fibrillation who are ineligible for oral anticoagulation had 75 percent fewer ischemic strokes and system embolisms if they received the Watchman left atrial appendage occlusion device than if they received aspirin alone.

During the first quarter of 2016, Corindus Vascular Robotics, Inc. increased its revenue to $1.1 million, up from $800,000 in the same period last year. The company also installed two new CorPath systems during the quarter, increasing the installed base to 40 systems, including 37 in the U.S. and three internationally.

Men and women who underwent transcatheter aortic valve replacement (TAVR) had similar rates of survival, major adverse cardiovascular events and vascular complications at 30 days, according to a randomized trial.

Patients who received moderate anesthesia while undergoing percutaneous transcatheter aortic valve replacement (TAVR) had a shorter length of stay in the hospital and lower 30-day mortality compared with patients who received general anesthesia, according to an observational registry analysis.

Patients at risk for contrast-induced acute kidney injury while undergoing coronary angiography had a 15.5 percent relative reduction in contrast media volume when using the Avert system (Osprey Medical), according to a prospective, multicenter, randomized trial.